ArticleApplied microbiology and biotechnology2025

Recombinant CD80 fusion protein combined with discoidin domain receptor 1 inhibitor for cancer treatment.

Songna Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.